Hydroxychloroquine treatment for recurrent pregnancy loss: a study protocol for a randomized, double-blind, placebo-controlled trial

Data Availability

When the clinical trial ends, the anonymized data will be made available to other researchers through public databases such as the Zenodo open data repository (CERN) or other equivalent databases. Trial data will be available for other researchers after they obtain data permission to do this.